Proprietary Technologies

Our Technologies Drive Industry-Leading Yields and Timelines

Optimize yield, reduce impurities, and accelerate timelines across therapeutic development using ProBio’s proprietary technologies. From discovery, development to manufacturing of antibodies, viral vector, plasmid DNA and mRNA, our platforms guide success for clinical and commercial programs.

Featured Technologies

Single B Cell Screening

Our Single B Cell Screening platform utilizes advanced microfluidics to isolate and analyze individual B cells, enabling the rapid discovery of high-affinity antibodies within weeks. This technology accelerates development timelines while delivering therapeutic candidates with exceptional specificity and potency.

See Our Other Antibody Discovery Technologies